Back

The association between elevated systemic inflammation response index and long-term mortality in patients with triple-vessel coronary disease.

31 August 2024 (10:00 - 10:40)
Organised by: Logo
Congress Presentation Part of: Cardiovascular diseases: predictors of onset and prognosis Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Qinxue Li

Fuwai Hospital, CAMS and PUMC, Beijing (China)

6 More presentations in this session

Presentation thumbnail
Coronary artery disease polygenic risk score in patients undergoing coronary angiography and risk of future revascularization
Mr K. Supriami (Boston, US)
Abstract Slides Video
Presentation thumbnail
Proenkephalin improves risk prediction in acute coronary syndromes: derivation and external validation of the KID-ACS risk score
Mr P. Wang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Development and validation of a prognostic score integrating remote heart failure symptoms and clinical variables for mortality risk prediction after myocardial infarction. The PragueMi score.
Doctor P. Wohlfahrt (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Single spot albumin to creatinine ratio as an independent predictor of 12 years follow-up mortality in acute coronary syndromes without ST-segment elevation
Doctor C. Higa (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Predictors of 1-year follow-up period MACE in patients with NSTEMI
Mr I. Popovici (MD)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular diseases: predictors of onset and prognosis

The Event

Event poster

ESC Congress 2024

31 August 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Comparative predictive value of SIRI and GRACE risk score for in-hospital mortality in NSTEMI patients
thumbnail
Congress Session
Secondary prevention: biomarkers to optimise outcomes
thumbnail
Congress Presentation
ORBI risk score and inflammatory response in patients with acute ST-elevation myocardial infarction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources